Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population

Asian Journal of Andrology

Volumn 11, Issue 3, 2009, Pages 351-355

  Ozbek, Emin ^a   Tasci, Ali I ^b   Tugcu, Volkan ^b   Ilbey, Yusuf O ^a   Simsek, Abdulmuttalip ^a   Ozcan, Levent ^a   Polat, Emre C ^a   Koksal, Vedat ^c  

^a Educational Hospital   (Turkey)

^b Bakirkoy Research and Education Hospital ^*  (Turkey)

^c Burc Genetic Diagnosis Laboratory   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROSEXUAL MALE; HUMAN; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREMATURE EJACULATION; PROMOTER REGION; EJACULATION; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; SEXUAL DYSFUNCTION; TURKEY (REPUBLIC);

ADULT; EJACULATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TURKEY; YOUNG ADULT;

EID: 69249213650     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2008.3     Document Type: Article

References (25)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association; 1994.
2. Goldstein I. Premature to early ejaculation: A sampling of manuscripts regarding the most common male sexual dysfunction published in the IJIR: The Journal of Sexual Medicine. Int J Impot Res 2003; 15: 307-8.
3. Godpodinoff ML. PE: Clinical subgroups and etiology. J Sex Marital Ther 1989; 15: 130-4.
4. Williams W. Secondary PE. Aust N Z J Psychiatry 1984; 18: 333-40.
5. Waldinger MD. Emerging drugs for PE. Expert Opin Emerg Drugs 2006; 11: 99-109.
6. Crenshaw R. Prozac and PE. Annual Meeting of the American Association of Sex Educators, Counselors and Therapist; Orlando, FL, USA; 1992.
7. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-81.
8. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of PE: A double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 151: 1377-9.
9. Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculationretarding properties of paroxetine in patients with primary PE: A double-blind, randomized, dose-response study. Br J Urol 1997; 79: 592-5.
10. Mendels J, Camera A, Sikes C. Sertraline treatment for PE. J Clin Psychopharmacol 1995; 15: 341-6.
11. Waldinger MD, Rietschel M, Nöthen MM, Hengeveld MW, Olivier B. Familial occurrence of primary PE. Psychiatr Genet 1998; 8: 37-40.
12. Gurkan L, Oommen M, Hellstrom WJ. premature ejaculation: Current and future treatments. Asian J Androl 2008; 10: 102-9.
13. Heils A, Teufel A, Petri S, Stöber G, Riederer P, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-4.
14. Kaiser R, Tremblay PB, Roots I, Brockmoller J. Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin Biochem 2002; 35: 49-56.
15. Andersson G, Larsson K. Effects of FG 5893, a new compound with 5-HT1A receptor agonistic and 5-HT2 receptor antagonistic properties, on male rat sexual behavior. Eur J Pharmacol 1994; 255: 131-7.
16. Robinson BW, Mishkin M. Ejaculation evoked by stimulation of the preoptic area in monkeys. Physiol Behav 1966; 1: 269-72.
17. Marson L, McKenna KE. The identification of a brainstem site controlling spinal sexual reflexes in male rats. Brain Res 1990; 515: 303-8.
18. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-7.
19. Waldinger MD. Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs 1996; 6: 204-16.
20. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
21. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-9.
22. Little KY, McLaughlin DP, Zhang L, McFinton PR, Dalack GW, et al. Brain dopamine transporter messenger RNA and binding sites in cocaine users: A postmortem study. Arch Gen Psychiatry 1998; 55: 793-9.
23. Lee MS, Lee HY, Lee HJ, Ryu SH. Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment. Psychiatr Genet 2004; 14: 111-5.
24. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994; 40: 288-95.
25. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, et al. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Brain Res Mol Brain Res 1993; 17: 31-5.